KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
$24.50
0.00%
(0.00) 1D
Oct 1, 10:21:43 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KSPHF...
Mkt. cap
172.67B
Avg. vol.
20.00
Volume
0.00
52-wk high
$31.90
52-wk low
$24.50
Beta
13.94
Shares outstanding
46.54M
No. of employees
2K
Mkt. cap
172.67B
Avg. vol.
20.00
Volume
0.00
52-wk high
$31.90
52-wk low
$24.50
Beta
13.94
Shares outstanding
46.54M
No. of employees
2K
News stories
From web sources and news partners
TipRanks
·
40 minutes ago
Vanguard S&P 500 ETF Sees Inflows Amid Mixed Tech Performance
MarketWatch
·
6 hours ago
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
NTD News
·
2 hours ago
Wall Street Review: S&P 500 Closes Near All-Time High
The Motley Fool
·
1 hour ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1.79K
FoundedAug 9, 1946
HeadquartersMatsumoto, Nagano, Japan
SectorPharmaceutical industry
Websitekissei.co.jp